帕利哌酮和奥氮平对首发精神分裂症患者血脂代谢影响的研究(3)
参见附件。
参考文献
[1]FOWLER JA.BETTINGER TL,ARGO TR. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia[J].Clin ther 2008.30(2):231-248
[2]Hermids T. Weight gain associated with atypical antipsychotics [J]. J Am Acad Child Adolesc Psychiatry,2002,(41):1272~1273.
[3]于 欣,司天梅.精神药理学精要:处方指南[M]. 北京大学出版社,2009:450-452.
[4]甘全喜,张小智.齐拉西酮与奥氮平治疗女性精神分裂症的对照研究[J]. 中国民康医学,2009,21(22):2802.
[5]MARDER SR.KRAMER M,FORD L, et al Efficacy and safety of Paliperidone extended-release tablets Results of a 6-week,rando-mized,placebocontrolled study[J]. Biol Psychiatry,2007.62(12):1363-1370
[6]DAVIDSON M.EMSLEY R,KRAMER M, et al Efficacy, safety and early response of Paliperidone extended-release tablets(Paliperidone ER):Results of a 6-week rando-mized,placebocontrolled study[J]. Schizopr Res, 2007.93(1-3):117-130
[7]VERMEIRM, NAESSENS REMMERIE B, et al Absorption. Metabolism, and exertion of Paliperidone, a new monoamincrgic antagonist, in humans[J]. Dmg Metab Dispos, 2008.36(4):769-779
参考文献
[1]FOWLER JA.BETTINGER TL,ARGO TR. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia[J].Clin ther 2008.30(2):231-248
[2]Hermids T. Weight gain associated with atypical antipsychotics [J]. J Am Acad Child Adolesc Psychiatry,2002,(41):1272~1273.
[3]于 欣,司天梅.精神药理学精要:处方指南[M]. 北京大学出版社,2009:450-452.
[4]甘全喜,张小智.齐拉西酮与奥氮平治疗女性精神分裂症的对照研究[J]. 中国民康医学,2009,21(22):2802.
[5]MARDER SR.KRAMER M,FORD L, et al Efficacy and safety of Paliperidone extended-release tablets Results of a 6-week,rando-mized,placebocontrolled study[J]. Biol Psychiatry,2007.62(12):1363-1370
[6]DAVIDSON M.EMSLEY R,KRAMER M, et al Efficacy, safety and early response of Paliperidone extended-release tablets(Paliperidone ER):Results of a 6-week rando-mized,placebocontrolled study[J]. Schizopr Res, 2007.93(1-3):117-130
[7]VERMEIRM, NAESSENS REMMERIE B, et al Absorption. Metabolism, and exertion of Paliperidone, a new monoamincrgic antagonist, in humans[J]. Dmg Metab Dispos, 2008.36(4):769-779
您现在查看是摘要介绍页,详见PDF附件。